Reports Q3 revenue $68.03M, consensus $61.22M. Reports total members of 831,000, up 53%. “Our third quarter results demonstrate the strength of Omada’s multi-product platform in a moment of intense national focus on obesity-related chronic disease,” said Sean Duffy, Co-founder and CEO of Omada Health (OMDA). “We also took important steps to deepen our innovation in GLP-1 care options and advance our AI capabilities, both aimed at delivering meaningful and sustainable outcomes for our members and cost savings for customers.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMDA:
- Omada Health to present RWE on behavior change program at ObesityWeek
- Omada Health, Inc.: Strategic Growth and Market Penetration Drive Buy Rating
- Omada Health appoints Tsang as Chief Medical Officer
- Omada Health price target raised to $28 from $24 at Barclays
- Omada Health’s Surge in App Downloads and GLP-1 Care Track Expansion Justify Buy Rating